If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
I never understood where the $100 calls were coming from. Iran sanctions had already been priced in. Saudi output has increased as too has Libya. Think it was way overpriced at $85 and a fair price is probably closer to $70 which would be in line with most the calls made a few month ago. What I can't get my head round is how much the oil stocks get punished when poo comes down, much more so than how they are rewarded when it goes up. The likes of G and TLW etc are all increasing revenues and improving balance sheets with oil at current level, so why the huge sell off?
Not much more they can say but they do have actions available to them. Aside from share buy back, they could do some meaningful director buys (i.e. more than £20K in value). That would help IMO and would certainly eradicate any fears of something more untoward being in play here.
I guess it's good news that both are still in the mix. Could it be there is a bidding war going on?
What's the meaning of the last two RNS relating the Apollo and Bain?
same as always....vague musings about discussions. The BOD are incapable of delivering on anything. The long made point that they hold hardly any shares between them speaks volumes......they don't even back themselves. I actually fell asleep listening to that interview yesterday afternoon. He is a great cure for insomnia but not someone you want to be counting on to deliver value on your investment. Neither is CEO. God knows what she does on a day to day basis other than take a nice salary for doing very little.
I'm with Bakky. Can't see how a negotiated settlement between the two parties can come about now after this length of time. Illumina have no reason to relax their negotiation position and if it was they put on the table was unacceptable to us in the past then it has to be unacceptable now. This is going all the way to appeal next year and then beyond.
For me the bad deal comment was definitely a joke said tongue in cheek. However, it was a silly joke to make in these circumstances where shareholder value is non existent. And therein lies the problem with this BOD.......they have little interest in delivering value to shareholders and instead see them only as a funding source to enable them to carry out their important work towards developing cancer drugs. i.e. shareholder value if it occurs will be a by-product of their success in achieving this. Some will argue that there isn't much wrong with that but i am not ashamed to say that as a capitalist all i want from this investment is share price value. If we can help others along the way then great. Therefore I would like a BOD who are completely focused on the commercials and delivering value to shareholders. Will be voting yes tomorrow as I don't see much choice but if there ever is a chance to replace some of these people i will jumping on to that bandwagon very quickly.
Flipper, what is happening next week?
I don't think the BOD are wanting to pursue the appeal but any settlement terms that been offered by Illumina are clearly unacceptable, assuming they have even made them. Surely we must assume that the new legal team has advised that we do have a chance of winning at appeal, otherwise the logical conclusion is, in the absence of a viable settlement offer, that we would have thrown in the towel and withdrawn NIPT from the UK market by now.
Think we have to work on the basis that we are seeing it through to appeal stage next year. Whilst lack of news is somewhat frustrating, one can only assume that the international growth is continuing